Home/Filings/4/0000899243-20-015153
4//SEC Filing

CATHERS BRIAN EDWIN 4

Accession 0000899243-20-015153

CIK 0001629137other

Filed

Jun 2, 8:00 PM ET

Accepted

Jun 3, 7:49 PM ET

Size

5.8 KB

Accession

0000899243-20-015153

Insider Transaction Report

Form 4
Period: 2020-06-01
Transactions
  • Award

    Restricted Stock Units

    2020-06-01+42,40042,400 total
    Common Stock (42,400 underlying)
Footnotes (2)
  • [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer's Common Stock.
  • [F2]The RSUs vest in installments conditioned upon the achievement, on or before June 30, 2024, of up to three specified market price thresholds of the Issuer, subject to the Reporting Person's continuous service with the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.

Issuer

Global Blood Therapeutics, Inc.

CIK 0001629137

Entity typeother

Related Parties

1
  • filerCIK 0001769127

Filing Metadata

Form type
4
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 7:49 PM ET
Size
5.8 KB